newsfilter
← Latest News
PR Newswire·

Longevity Acquisition Corporation Announces 4D pharma Update on Oncology Program

Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that on...